Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Looking for ways to get cash fast when unemployed? Act now to discover the best opportunities for immediate income!
20,927 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
New SSA data show most retirees start Social Security before age 70, missing the strongest move that could boost life...
A seasoned financial writer explains how a president-defining stance from the new Fed chair can ripple through stocks...
A familiar theme in energy investing is volatility followed by opportunity. This nuclear energy stock has recently fa...
Tesla reports a robust quarter with deliveries around 515,000, topping expectations and reigniting investor optimism....
Microsoft plans to cut more than 3,000 jobs in its Xbox division as part of a broader cost-reduction effort. The move...
Alibaba leads a broad rally in China’s tech and e-commerce sector as investors brace for quarterly results. Baidu and...
AMD faces another round of upgrades as AI infrastructure spending keeps demand alive. Analysts raise targets while in...
Dividend income can be a reliable part of a retirement plan. This guide shows the math behind earning $12,000 annuall...
Can a defense-focused ETF outperform a jet-fueled recovery play in 2026? This deep dive examines PPA and JETS, weighi...
Insider moves can spark questions for investors. This article unpacks what insider selling means, how to read Form 4 ...
Bond ETFs face a steady rate backdrop as the fed's benchmark rate 3.5%–3.75% holds. This guide breaks down what it me...